PMCN-M Stock Overview
Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Pharmocann Global Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪1.03 |
| 52 Week High | ₪3.05 |
| 52 Week Low | ₪0.51 |
| Beta | -0.14 |
| 1 Month Change | -40.05% |
| 3 Month Change | -45.79% |
| 1 Year Change | -62.27% |
| 3 Year Change | -99.44% |
| 5 Year Change | n/a |
| Change since IPO | -99.66% |
Recent News & Updates
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Shareholder Returns
| PMCN-M | IL Pharmaceuticals | IL Market | |
|---|---|---|---|
| 7D | 3.0% | 4.5% | -0.8% |
| 1Y | -62.3% | -11.2% | 7.1% |
Return vs Industry: PMCN-M underperformed the IL Pharmaceuticals industry which returned -10.7% over the past year.
Return vs Market: PMCN-M underperformed the IL Market which returned 7.8% over the past year.
Price Volatility
| PMCN-M volatility | |
|---|---|
| PMCN-M Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.0% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: PMCN-M's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PMCN-M's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 20 | Gil Paramedic | www.pharmacann.co.il |
Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. It provides cannabis to treat patients with depression and Alzheimer's. The company produces tons of processed cannabis.
Pharmocann Global Ltd Fundamentals Summary
| PMCN-M fundamental statistics | |
|---|---|
| Market cap | ₪2.52m |
| Earnings (TTM) | -₪9.73m |
| Revenue (TTM) | ₪14.41m |
0.2x
P/S Ratio-0.3x
P/E RatioIs PMCN-M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMCN-M income statement (TTM) | |
|---|---|
| Revenue | ₪14.41m |
| Cost of Revenue | ₪15.78m |
| Gross Profit | -₪1.37m |
| Other Expenses | ₪8.36m |
| Earnings | -₪9.73m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.98 |
| Gross Margin | -9.51% |
| Net Profit Margin | -67.54% |
| Debt/Equity Ratio | 11.2% |
How did PMCN-M perform over the long term?
See historical performance and comparison